Polar Capital Funds plc - Biotechnology Fund Class R GBP Distribution Shares
IE00B3XDCF51
Polar Capital Funds plc - Biotechnology Fund Class R GBP Distribution Shares/ IE00B3XDCF51 /
NAV23/08/2024 |
Diferencia+0.3700 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
36.0300GBP |
+1.04% |
paying dividend |
Equity
Worldwide
|
Polar Capital ▶ |
Estrategia de inversión
The objective of the Fund is to preserve capital and achieve long term capital appreciation by investing worldwide in the shares of biotechnology, diagnostics and life sciences tools companies.
The Fund is broadly diversified across countries, biotechnology sectors and by market-cap (a measure of company size). The Fund may invest in financial derivatives (complex instruments based upon the value of underlying assets) for hedging, to reduce risk, to manage the Fund more efficiently, or to gain exposure to securities in a more efficient way. The Fund is actively managed and uses the NASDAQ Biotechnology Net Total Return Index (EUR) benchmark as a performance target and to calculate the performance fee. The currency of the Fund is US Dollar and the currency of this share class is Euro (EUR). Any income which the Fund generates may be paid out in the form of an annual dividend at the sole discretion of the Directors.
Objetivo de inversión
The objective of the Fund is to preserve capital and achieve long term capital appreciation by investing worldwide in the shares of biotechnology, diagnostics and life sciences tools companies.
Datos maestros
Tipo de beneficio: |
paying dividend |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Biotechnology |
Punto de referencia: |
NASDAQ Biotechnology Net Total Return Index (EUR) |
Inicio del año fiscal: |
01/01 |
Última distribución: |
- |
Banco depositario: |
Northern Trust Fiduciary Serv. (IE) Ltd |
País de origen: |
Ireland |
Permiso de distribución: |
Austria, Germany, Switzerland |
Gestor de fondo: |
David Pinniger |
Volumen de fondo: |
- |
Fecha de fundación: |
31/10/2013 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
5.00% |
Max. Comisión de administración: |
1.50% |
Inversión mínima: |
0.00 GBP |
Deposit fees: |
- |
Cargo por amortización: |
0.00% |
Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
Fondos de empresa: |
Polar Capital |
Dirección: |
16 Palace Street, SW1E 5JD, London |
País: |
United Kingdom |
Internet: |
www.polarcapital.co.uk
|
Activos
Stocks |
|
99.03% |
Cash |
|
0.21% |
Otros |
|
0.76% |
Países
United States of America |
|
65.93% |
Netherlands |
|
8.14% |
Denmark |
|
6.29% |
Sweden |
|
5.01% |
Canada |
|
3.24% |
United Kingdom |
|
3.21% |
Belgium |
|
2.94% |
Ireland |
|
1.19% |
France |
|
1.10% |
Bermuda |
|
0.89% |
Germany |
|
0.71% |
Cash |
|
0.21% |
Otros |
|
1.14% |
Sucursales
Pharma/Biotechnology |
|
97.87% |
Healthcare services |
|
0.67% |
Cash |
|
0.21% |
Gesundheitswesen/ Informationstechnologie |
|
0.11% |
Otros |
|
1.14% |